Nilotinib (NIL) vs. NIL plus Peg-Interferon alpha (IFN) Induction and NIL or IFN Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients. The TIGER Trial A. Hochhaus,A. Burchert,S. Saussele, G. M. Baerlocher, J. Mayer,T. H. Bruemmendorf,P. La Rosee, D. Heim,S. W. Krause,P. Le Coutre,C. Fabisch,J. Rinke, T. Lange, A. Fabarius, M. Lorch,M. Haenel,F. Stegelmann,G. -N Franke, M. Radsak,V Kunzmann,D. Zackova, D. Himsel, D. Kohn, T. Lang, R. Hehlmann, T. Ernst,M. PfirrmannONCOLOGY RESEARCH AND TREATMENT（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
